296 related articles for article (PubMed ID: 32062567)
41. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
[TBL] [Abstract][Full Text] [Related]
42. Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?
Andravizou A; Siokas V; Artemiadis A; Bakirtzis C; Aloizou AM; Grigoriadis N; Kosmidis MH; Nasios G; Messinis L; Hadjigeorgiou G; Dardiotis E; Peristeri E
Neurol Res; 2020 Jul; 42(7):575-586. PubMed ID: 32427076
[TBL] [Abstract][Full Text] [Related]
43. A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.
Prinster A; Quarantelli M; Lanzillo R; Orefice G; Vacca G; Carotenuto B; Alfano B; Brunetti A; Morra VB; Salvatore M
Mult Scler; 2010 Jan; 16(1):45-54. PubMed ID: 20028706
[TBL] [Abstract][Full Text] [Related]
44. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
45. Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates.
Rekik A; Aissi M; Rekik I; Mhiri M; Frih MA
Brain Behav; 2022 May; 12(5):e2573. PubMed ID: 35398999
[TBL] [Abstract][Full Text] [Related]
46. The role of cerebellar damage in explaining disability and cognition in multiple sclerosis phenotypes: a multiparametric MRI study.
Bonacchi R; Meani A; Pagani E; Marchesi O; Filippi M; Rocca MA
J Neurol; 2022 Jul; 269(7):3841-3857. PubMed ID: 35230471
[TBL] [Abstract][Full Text] [Related]
47. Disruption of the Atrophy-based Functional Network in Multiple Sclerosis Is Associated with Clinical Disability: Validation of a Meta-Analytic Model in Resting-State Functional MRI.
Chiang FL; Feng M; Romero RS; Price L; Franklin CG; Deng S; Gray JP; Yu FF; Tantiwongkosi B; Huang SY; Fox PT
Radiology; 2021 Apr; 299(1):159-166. PubMed ID: 33529135
[TBL] [Abstract][Full Text] [Related]
48. Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers.
Bussas M; Grahl S; Pongratz V; Berthele A; Gasperi C; Andlauer T; Gaser C; Kirschke JS; Wiestler B; Zimmer C; Hemmer B; Mühlau M
Mult Scler; 2022 May; 28(6):900-909. PubMed ID: 34591698
[TBL] [Abstract][Full Text] [Related]
49. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
[TBL] [Abstract][Full Text] [Related]
50. Cortical quantitative MRI parameters are related to the cognitive status in patients with relapsing-remitting multiple sclerosis.
van Wijnen A; Petrov F; Maiworm M; Frisch S; Foerch C; Hattingen E; Steinmetz H; Klein JC; Deichmann R; Wagner M; Gracien RM
Eur Radiol; 2020 Feb; 30(2):1045-1053. PubMed ID: 31602513
[TBL] [Abstract][Full Text] [Related]
51. Reduced Global Efficiency and Random Network Features in Patients with Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment.
Hawkins R; Shatil AS; Lee L; Sengupta A; Zhang L; Morrow S; Aviv RI
AJNR Am J Neuroradiol; 2020 Mar; 41(3):449-455. PubMed ID: 32079601
[TBL] [Abstract][Full Text] [Related]
52. Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.
Rojas JI; Murphy G; Sanchez F; Patrucco L; Fernandez MC; Miguez J; Funes J; Golimstok A; Cristiano E
Neuroradiol J; 2018 Aug; 31(4):350-355. PubMed ID: 29869576
[TBL] [Abstract][Full Text] [Related]
53. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
[TBL] [Abstract][Full Text] [Related]
54. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
[TBL] [Abstract][Full Text] [Related]
55. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
56. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
[TBL] [Abstract][Full Text] [Related]
57. Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.
Singhal T; O'Connor K; Dubey S; Pan H; Chu R; Hurwitz S; Cicero S; Tauhid S; Silbersweig D; Stern E; Kijewski M; DiCarli M; Weiner HL; Bakshi R
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e587. PubMed ID: 31355321
[TBL] [Abstract][Full Text] [Related]
58. No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.
Donohue K; Cox JL; Dwyer MG; Aliotta R; Corwin M; Weinstock-Guttman B; Ann Yeh E; Zivadinov R
J Neuroimaging; 2014; 24(1):63-7. PubMed ID: 23317029
[TBL] [Abstract][Full Text] [Related]
59. Benefits of a mosaic approach for assessing cortical atrophy in individual multiple sclerosis patients.
Tahedl M; Wiltgen T; Voon CC; Berthele A; Kirschke JS; Hemmer B; Mühlau M; Zimmer C; Wiestler B
Brain Behav; 2023 Dec; 13(12):e3327. PubMed ID: 37961043
[TBL] [Abstract][Full Text] [Related]
60. Investigation of grey matter abnormalities in multiple sclerosis patients by combined use of double inversion recovery sequences and diffusion tensor MRI at 3.0 Tesla.
Han X; Wang X; Wang L; Zheng Z; Gu J; Tang D; Liu L; Liu S
Clin Radiol; 2018 Sep; 73(9):834.e17-834.e23. PubMed ID: 29861163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
